# Evaluation of the Safety and Efficacy of Artificial Bone Repair Materials for Repair of Long Bone Defects in the Extremities

> **NCT06959459** · NA · NOT_YET_RECRUITING · sponsor: **Chinese PLA General Hospital** · enrollment: 156 (estimated)

## Conditions studied

- Bone Defects of the Limbs

## Interventions

- **DEVICE:** Intervention Group:Use of artificial bone repair materials produced by Changzhou Bone-Renewal Medical Technologies LLC.
- **DEVICE:** Control group: Use of β-tricalcium phosphate bioceramics produced by Shanghai Biolu Biomaterials Co., Ltd.

## Key facts

- **NCT ID:** NCT06959459
- **Lead sponsor:** Chinese PLA General Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-05-10
- **Primary completion:** 2026-04-30
- **Final completion:** 2026-12-30
- **Target enrollment:** 156 (ESTIMATED)
- **Last updated:** 2025-05-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06959459

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06959459, "Evaluation of the Safety and Efficacy of Artificial Bone Repair Materials for Repair of Long Bone Defects in the Extremities". Retrieved via AI Analytics 2026-07-15 from https://api.ai-analytics.org/clinical/NCT06959459. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*